What is the recommended dosing frequency for Buscopan (hyoscine butylbromide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Buscopan Dosing Frequency

For abdominal cramping pain, Buscopan (hyoscine butylbromide) should be dosed at 10-20 mg per dose, up to 3-4 times daily, with a maximum of 60-100 mg per day depending on the indication.

Standard Dosing Regimens

The dosing frequency varies based on the clinical context:

For Irritable Bowel Syndrome and Functional Abdominal Pain

  • On-demand dosing: 20 mg as needed when cramping occurs, with the option to repeat every 30 minutes up to 4 additional doses (maximum 100 mg/day) 1
  • Scheduled dosing: 10 mg three times daily (30 mg/day total) has been studied in clinical trials for IBS 2
  • The AGA guidelines suggest using antispasmodics like hyoscine for IBS patients, though this is a conditional recommendation based on low-certainty evidence 3

For Dysmenorrhea (Menstrual Pain)

  • 1-2 tablets three times daily, with each tablet containing 10 mg hyoscine butylbromide (when combined with paracetamol in Buscopan Plus formulation)
  • Maximum limit: 3 g paracetamol per day when using combination products 4

For Palliative Care (Death Rattle/Bowel Obstruction)

  • 60 mg daily via subcutaneous administration is the standard dose 5, 6
  • Prophylactic administration is significantly more effective than waiting until symptoms occur 5

Clinical Considerations

The on-demand approach is particularly effective for self-reported functional cramping abdominal pain. Studies demonstrate that patients achieve clinically meaningful pain reduction (≥2 points on an 11-point scale, representing ~30% pain relief) within 45 minutes of HBB administration versus 60 minutes with placebo 1.

Common Pitfalls to Avoid

  • Don't wait too long to administer: In palliative care settings, prophylactic use prevents death rattle in 94% of patients, while late administration after symptom onset is effective in only 20% 5
  • Consistent timing matters: While on-demand use is validated, scheduled dosing may be preferable for predictable symptoms
  • Monitor for anticholinergic effects: Dry mouth, dizziness, and blurred vision are the most common adverse events, though serious events are rare 3

Mechanism and Onset

HBB works as an anticholinergic antispasmodic that reduces smooth muscle contraction. Pain relief typically begins within 30-45 minutes, with meaningful relief by 37.5 minutes (median) 4, 1. The drug has poor systemic absorption, which limits central nervous system side effects while maintaining gastrointestinal efficacy 7.

Note: The evidence provided includes references to "buspirone" 8, which is an entirely different medication (an anxiolytic) and should not be confused with Buscopan (hyoscine butylbromide). These references are not applicable to the question.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.